About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Dengue Infection Induced Diffuse Alveolar Hemorrhage
Vishal Singh1, Satish Chandra Mishra2, Pulkit Singh3, Pradeepa AM4
1Division of Nephrology, Department of Medicine, 7 AF Hospital, Kanpur, Uttar Pradesh, India; 2Department of Interventional Cardiology, Military Hospital (CTC), Pune, Maharashtra, India; 3MS Ramaiah Medical College, Bangalore, Karnataka, India; 4Department of Medicine, 7 AF Hospital, Kanpur, Uttar Pradesh, India.
Corresponding Author:
Dr Vishal Singh
Email: vishal23415@gmail.com
Received: 26-DEC-2019 Accepted: 26-MAR-2020 Published Online: 05-APR-2020
DOI: http://dx.doi.org/10.17659/01.2020.0018
Abstract
Background: Dengue fever is a commonly encountered arthropod-borne viral disease. The spectrum of the disease varies widely, and at times it may present with unusual complications. One such dreaded but rare complication is diffuse alveolar hemorrhage (DAH). Case Report: A 42 years old lady having no co-morbidities presented with dengue infection. The presentation included fever, gum bleed, and asthenia. The examination showed low oxygen saturation and clear chest. The discordance between clinical findings and the oxygen saturation led to a cascade of investigations, culminating in the diagnosis of DAH. She was managed symptomatically, with full recovery. Conclusion: DAH is an uncommon, life-threatening, complication of dengue infection. A high index of suspicion, prompt evaluation and early institution of appropriate therapy hold the key to successfully manage such patients.
Keywords : Arbovirus Infections, Dengue, Fever, Hemorrhage, Oxygen.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Dec 04, 2024